Article
Clinical and molecular characterization of patients with juvenile myelomonocytic leukaemia.
British journal of haematology - 1 Nov 2025
Meyer Julia A, Xirenayi Sherin, Werner Juwita, Turakulov Rust, Hechmer Aaron, Abdullaev Zied, Hamdy Nayera, Olshen Adam, Stieglitz Elliot, Hammad Mahmoud, Elhaddad Alaa
Abstract excerpt
Juvenile myelomonocytic leukaemia (JMML) is a rare haematological malignancy caused by mutations in the Ras signalling pathway. Next-generation sequencing (NGS) and DNA methylation profiling used for diagnostic and risk stratification purposes are now standard of care in Europe and the United States for patients with JMML. To better understand how implementing these types of technologies would impact the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
